Does LENVATINIB Cause Product use issue? 625 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 625 reports of Product use issue have been filed in association with LENVATINIB (Lenvima). This represents 1.9% of all adverse event reports for LENVATINIB.
625
Reports of Product use issue with LENVATINIB
1.9%
of all LENVATINIB reports
28
Deaths
139
Hospitalizations
How Dangerous Is Product use issue From LENVATINIB?
Of the 625 reports, 28 (4.5%) resulted in death, 139 (22.2%) required hospitalization, and 5 (0.8%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENVATINIB. However, 625 reports have been filed with the FAERS database.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which LENVATINIB Alternatives Have Lower Product use issue Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE